Health Condition 1: X- New Technology
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
EasyfyHealthcare Pvt Ltd,
Eligibility
Inclusion criteria
Inclusion criteria: Histologically confirmed malignancy Planned intravenous chemotherapy suitable for decentralised administration ECOG performance status 0-2 Ability to provide informed consent
Exclusion criteria
Exclusion criteria: High risk Chemotherapy requiring ICU level monitoring Chemotherapy protocol involving consecutive days chemo Unstable comorbid conditions Patients unwilling or unable to comply with digital followup
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of chemotherapy related Grade , Proportion of planned Chemotherapy cycles completed using EasyfyCare,Proportion of cases with complete digital workflow documentationTimepoint: The primary outcome was assessed over a six months study period | — |
Secondary
| Measure | Time frame |
|---|---|
| Acceptance of EasyfyCare (Patient, nurse & clinician satisfaction scores), Time Saved (Reduction in travel time & hospital visits, Cost Savings( reduction in out of pocket expenditure like travel accomadation,wageloss),Dropouts(Chemotherapy discontinuation & loss to follow up rates),Supportive Care Utilisation( Number of unplanned emergency visits or hospital admissions)Timepoint: The secondary outcome was assessed over a six months time period | — |
Countries
India
Contacts
Public ContactKavitha VC
MVR Cancer Centre and Research Institute
Outcome results
None listed